GENESIS Pharma
Vivi Chatzaki is a seasoned professional in the oncology field with extensive experience in medical science liaison and regional medical liaison roles. Currently serving as a Medical Science Liaison at Ipsen since July 2018, Vivi previously held various positions at Genesis Pharma starting in June 2007, including Regional Medical Liaison for oncology and hematology, Med Info & Clinical Trial Associate, and Oncology Product Specialist. Prior experience includes a role as a Product Specialist in cardiology with AstraZeneca from January 2004 to June 2007. Vivi Chatzaki holds a degree from Ethnikon kai Kapodistriakon Panepistimion Athinon.
This person is not in any offices
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com